TG Therapeutics, Inc. (LON:0VGI)
31.97
-1.93 (-5.69%)
At close: Jan 31, 2025
TG Therapeutics Employees
TG Therapeutics had 264 employees as of December 31, 2023. The number of employees increased by 38 or 16.81% compared to the previous year.
Employees
264
Change (1Y)
38
Growth (1Y)
16.81%
Revenue / Employee
619.31K GBP
Profits / Employee
-33.60K GBP
Market Cap
3.51B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 89,900 |
GSK plc | 70,212 |
Haleon | 25,408 |
Smith & Nephew | 18,452 |
Hikma Pharmaceuticals | 9,100 |
ConvaTec Group | 10,136 |
HUTCHMED (China) | 1,988 |
Genus | 3,500 |
TG Therapeutics News
- 5 days ago - 20 stocks of companies expected to put up numbers to back investors' new ‘growth mindset' - Market Watch
- 11 days ago - MaxCyte, TG Therapeutics sign strategic platform license to advance autoimmune cell therapeutics programs - Seeking Alpha
- 4 weeks ago - TG Therapeutics: Entering 2025 With Increased Investor Expectations - Seeking Alpha
- 4 weeks ago - TG Therapeutics: 2025 Revenues Will Smash Expectations - Seeking Alpha
- 5 weeks ago - TG Therapeutics: Cash Positive But Playing Defense (Rating Downgrade) - Seeking Alpha
- 5 weeks ago - What's Going On With TG Therapeutics Stock Tuesday? - Benzinga
- 5 weeks ago - TG Therapeutics says 2024 Briumvi sales topped expectations - Seeking Alpha
- 5 weeks ago - TG Therapeutics Inc (TGTX) Announces Strong Preliminary Revenue for BRIUMVI in 2024 - GuruFocus